29 results
8-K
EX-2.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
or more of the Seller Entities.
“Packaging Materials” means any information (including prescription information such as labeling and package inserts … , indications and safety instructions), packaging (including any boxes or other containers) and similar materials in each case relating to the packaging
DEFA14A
EX-2.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Additional proxy soliciting materials
9:17pm
or more of the Seller Entities.
“Packaging Materials” means any information (including prescription information such as labeling and package inserts … , indications and safety instructions), packaging (including any boxes or other containers) and similar materials in each case relating to the packaging
DEFM14A
m4kcku2z19x44zm
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
zesu34t67726w lspe6b
29 Jan 21
Preliminary proxy related to merger
4:22pm
8-K
EX-1.1
nbhnpjpwb
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
8-K
EX-1.1
xiy9v5 l2gitj
11 Dec 14
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
12:00am
S-1
EX-10.13
n1dy77men3 t4unfo79
10 Jun 13
IPO registration
12:00am
S-3ASR
EX-1.2
ez4qouj
30 Apr 20
Automatic shelf registration
4:19pm
424B4
waper6tew5392l
24 Apr 14
Prospectus supplement with pricing info
12:00am